LAVA Medtech Acquisition Corp. Unit
LVACU
LVACU was delisted on the 19th of April, 2023.
6 hedge funds and large institutions have $1.76M invested in LAVA Medtech Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 6 closing their positions.
45% less funds holding
Funds holding: 11 → 6 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
84% less capital invested
Capital invested by funds: $11.1M → $1.76M (-$9.31M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$3.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$6.03M |
| 2 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$2.01M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$605K |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$422K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$251K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIM
1
Cowen Investment Management
New York
| $1.02M | – | – | – |
|
|
SIA
2
Schechter Investment Advisors
Birmingham,
Michigan
| $378K | -$10.1K | -1,000 | -3% |
|
3
Walleye Capital
New York
| $309K | – | – | – |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $44.7K | -$121 | -12 | -0.3% |
|
|
GCL
5
Glazer Capital LLC
New York
| $3K | +$3.03K | +300 | New |
|
6
UBS Group
Zurich,
Switzerland
| $1.85K | – | – | – |
|
|
CCA
7
Castle Creek Arbitrage
Avon,
Colorado
| – | -$6.03M | -600,000 | Closed |
|
|
BCM
8
Basso Capital Management
Stamford,
Connecticut
| – | -$2.01M | -200,000 | Closed |
|
|
SSA
9
Schonfeld Strategic Advisors
New York
| – | -$605K | -59,964 | Closed |
|
|
WC
10
Wealthspring Capital
West Harrison,
New York
| – | -$422K | -42,000 | Closed |
|
|
LP
11
LMR Partners
London,
United Kingdom
| – | -$251K | -25,000 | Closed |
|
|
CCM
12
Condor Capital Management
Martinsville,
New Jersey
| – | -$10K | -1,000 | Closed |
|
LVACU Hedge Fund Activity: Q4 2022 in Review
6 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q4 2022, worth a combined $1.76M — down 84% from $11.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LVACU and 1 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $3.03K. The largest seller was Castle Creek Arbitrage, exiting entirely with an estimated $6.03M sold.
- 6 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q4 2022, down from 11 in Q3 2022.
- Funds reported $1.76M of LAVA Medtech Acquisition Corp. Unit stock for Q4 2022, down 84% quarter-over-quarter.
- 1 fund opened new LAVA Medtech Acquisition Corp. Unit positions in Q4 2022 and 6 closed out, a net change of -5 holders.
- The largest LAVA Medtech Acquisition Corp. Unit buyer in Q4 2022 was Glazer Capital LLC, an estimated $3.03K added.
- The largest LAVA Medtech Acquisition Corp. Unit seller in Q4 2022 was Castle Creek Arbitrage, an estimated $6.03M sold.
Based on aggregated 13F filings for Q4 2022.